Ken Griffin Forte Biosciences, Inc. Put Options Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Put Options
3 transactions
Others Institutions Holding FBRX
# of Institutions
33Shares Held
19MCall Options Held
3.1KPut Options Held
0-
Tybourne Capital Management (Hk) LTD Hong Kong, K33.62MShares$25.5 Million0.49% of portfolio
-
Perceptive Advisors LLC New York, NY3.27MShares$23 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$21 Million0.05% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$14.3 Million1.15% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$12.9 Million0.0% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $143M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.